Currently, a large number of coronaviruses are being registered in the country.  Vaccination is considered important in such cases.  Since 1 May, the central government has allowed vaccination for all people above 18 years of age.  Mass vaccination is said to be an alternative to combating corona.  A few days ago, after a meeting of vaccine manufacturers, the government allowed 50 percent of the total vaccine production to be sold in the open market.  Subsequently, Serum Institute of India and Bharat Biotech announced their vaccine rates.  But many criticized it for saying three rates for the same vaccine.  In addition, there was a growing demand for lower vaccine rates.  

Covaxin to be available to State governments at a price of Rs 400 per dose: Bharat Biotech  

In such a situation, on Wednesday, Serum lowered the rates for its Covishield lease to the states.  Since then, Bharat Biotech on Thursday cut rates for its vaccine vaccine for states.  Bharat Biotech will also make its vaccine available to the states at the rate of Rs 400 per dose.  On Wednesday, the Serum Institute lowered the rates of coviculated vaccine for the states.  Since then, Bharat Biotech has lowered its vaccine rates on Thursday.  Bharat Biotech will now provide vaccines to states at the rate of Rs 400 per dosa.  Bharat Biotech issued a statement in this regard.

The issue of vaccine pricing has been hotly debated after the two companies recently set a figure for what they will charge for their products amid the deadly second wave of the pandemic. Some leaders and political activists demanded universal free vaccination. However, the same companies recently requested billions of rupees from the center to make vaccines.

The Serum Institute of India has reduced the per capita price of Covishield vaccine by Rs 100.  Therefore, this vaccine will now be available for Rs. 300.  Adar Poonawala, the company's chief executive, tweeted that the decision was taken in the wider public interest.  According to the recent tariff, the covshield vaccine for 'serum' was to be given to the states at Rs 400.  There was a big objection from the states.  The same vaccine would have been available in private hospitals for Rs 600.  Developed by Oxford University and AstraZeneca, the corona preventive covshield vaccine 'Serum' is being manufactured in India.  Some states, including Maharashtra, have ordered vaccines from Serum Institute and Bharat Biotech in the wake of widespread vaccinations starting May 1.